A top prolific research clinician comments on GLP3
This is not approved in many nations. But in process by insurance companies and other research. Note that the starting dose of GLP-1, GLP-2 or GLP3 is grossly too high. Is this to make more money? This dose is extreme and only for rich obese patients. Even with no exercise or a change in cookies, over 70 […]
A top prolific research clinician comments on GLP3 Read More »